4//SEC Filing
LI WILLIAM 4
Accession 0001104659-24-106337
CIK 0001509745other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:24 PM ET
Size
5.8 KB
Accession
0001104659-24-106337
Insider Transaction Report
Form 4
LI WILLIAM
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-10-02+25,000→ 25,000 totalExercise: $2.45Exp: 2034-10-02→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of December 31, 2024, March 31, 2025, June 30, 2025, and September 30, 2025 for so long as the reporting person continues to be a director, consultant or service provider of the Company.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001273806
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 5:24 PM ET
- Size
- 5.8 KB